4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000005
CFO AND TREASURER sold 21,000 shares at an average $452.07 ($9,493,483)
- CFO AND TREASURER acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,000 | $146.03 | $3,066,630 | 29,118 | D |
| 2025-11-10 | Sale : show line 2 in the form 10b5-1 | −1,052 | $446.51 | $469,727 | 28,066 | D |
| 2025-11-10 | Sale : show line 3 in the form 10b5-1 | −1,539 | $447.47 | $688,655 | 26,527 | D |
| 2025-11-10 | Sale : show line 4 in the form 10b5-1 | −3,356 | $448.33 | $1,504,595 | 23,171 | D |
| 2025-11-10 | Sale : show line 5 in the form 10b5-1 | −653 | $449.00 | $293,197 | 22,518 | D |
| 2025-11-10 | Sale : show line 6 in the form 10b5-1 | −600 | $450.80 | $270,480 | 21,918 | D |
| 2025-11-10 | Sale : show line 7 in the form 10b5-1 | −1,065 | $451.87 | $481,240 | 20,853 | D |
| 2025-11-10 | Sale : show line 8 in the form 10b5-1 | −2,170 | $452.76 | $982,479 | 18,683 | D |
| Open-market sales · 21,000 sh · avg $452.07 · $9,493,483 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option | −21,000 | $146.03 | 2027-03-15 | 21,000 | 10,312 | D |
Loading xslF345X05/primarydocument.xml…